January 12, 2026 07:54 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
IPAC raid row escalates! ED drags Mamata Banerjee to Supreme Court after High Court chaos | 'Easy way or hard way': Trump doubles down on controversial push to acquire Greenland | Hindu tenant farmer shot dead in Pakistan’s Sindh, sparks massive protests | India vs NYC Mayor: MEA hits back after Mamdani backs jailed activist Umar Khalid | US Commerce Secretary blames India for trade deal failure: 'Modi didn’t call Trump' | Jana Nayagan controversy: Madras HC steps in, orders CBFC to clear Vijay film | Telecom shakeup: Vodafone Idea shares soar as AGR dues finally sorted | Dragged by police outside Amit Shah’s office! 8 TMC MPs detained as ED row explodes | Trump backs bill threatening 500% tariffs on India over Russian oil trade | ED alleges Mamata 'forcibly removed documents' during IPAC raids, CM calls Amit Shah 'nasty Home Minister'
Covid Vaccine
Image Credit: Pixabay

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

| @indiablooms | Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

Pfizer Inc and BioNTech stated that they have made a request to the US Food and Drug Administration for the expansion of use of their vaccine which proved to be 90 per cent effective against the novel coronavirus in clinical trials.

In March, the drugmakers said that their vaccine has shown positive results and proven safe among the age group 12 to 15 in a clinical trial.

This could be a big development as drugmakers across the world are still facing the question if the vaccine works and is safe for use in children.

Inoculating children is a major step toward achieving "herd immunity" and controlling the pandemic, according to experts, the report said.

The companies plan to approach other regulatory authorities across the globe for similar permissions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.